Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
REGAALNSE
BSHSLNSE
MGELNSE
SHEETAL-SMNSE
KOTYARKNSE
NATHBIOGENNSE
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 26% | 14% | 22% |
| - | 29% | 6% | 8% |
| -2% | -15% | -11% | -23% |
| 7% | 1% | 6% | 6% |
Peer Comparison
Symbol
KSCL
VENKEYS
AVTNPL
FRESHARA-ST
REGAAL
BSHSL
MGEL
SHEETAL-SM
KOTYARK
NATHBIOGEN
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 669.3 | ₹3416 Cr | 13.33 | -1.71 | 61.3 | ₹296 Cr |
| 1,560.6 | ₹2162 Cr | 12.47 | 35.48 | 149.6 | ₹139 Cr |
| 96.88 | ₹1436 Cr | 17.14 | 2.04 | 6.26 | ₹65 Cr |
| 386.9 | ₹951 Cr | 25.34 | 9.07 | 16.89 | ₹38 Cr |
| 85.5 | ₹903 Cr | 15.1 | 1.3 | 7.5 | ₹56 Cr |
| 85.59 | ₹881 Cr | 30.59 | 0.22 | 2.91 | ₹27 Cr |
| 17.09 | ₹564 Cr | 14.57 | 0.28 | 1.27 | ₹45 Cr |
| 391.9 | ₹466 Cr | 40.47 | 8.72 | 12.2 | ₹12 Cr |
| 38.44 | ₹416 Cr | 22.18 | 0.51 | 2.79 | ₹19 Cr |
| 133.48 | ₹250 Cr | 6.83 | 16.98 | 21.37 | ₹42 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹328 Cr | ₹52 Cr | ₹66 Cr | ₹44 Cr | ₹284 Cr | ₹52 Cr | ₹37 Cr | ₹32 Cr | ₹244 Cr | ₹43 Cr | ₹32 Cr | ₹23 Cr | ₹235 Cr | ₹45 Cr | ₹25 Cr | ₹22 Cr | ₹209 Cr | ₹27 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹48 L | ₹8 L | ₹13 L | ₹41 L | ₹4 L | ₹6 L | ₹12 L | ₹26 L | ₹6 L | ₹20 L | ₹4 L | ₹73 L |
| ₹330 Cr | ₹54 Cr | ₹68 Cr | ₹46 Cr | ₹285 Cr | ₹56 Cr | ₹37 Cr | ₹32 Cr | ₹244 Cr | ₹43 Cr | ₹32 Cr | ₹23 Cr | ₹235 Cr | ₹45 Cr | ₹25 Cr | ₹22 Cr | ₹209 Cr | ₹28 Cr |
| ₹294 Cr | ₹48 Cr | ₹63 Cr | ₹39 Cr | ₹255 Cr | ₹53 Cr | ₹30 Cr | ₹28 Cr | ₹208 Cr | ₹40 Cr | ₹27 Cr | ₹18 Cr | ₹199 Cr | ₹42 Cr | ₹20 Cr | ₹18 Cr | ₹176 Cr | ₹50 Cr |
| ₹37 Cr | ₹7 Cr | ₹5 Cr | ₹8 Cr | ₹31 Cr | ₹4 Cr | ₹9 Cr | ₹5 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹34 Cr | -₹21 Cr |
| ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| ₹33 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹29 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹34 Cr | ₹2 Cr | ₹5 Cr | ₹2 Cr | ₹33 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹31 Cr | -₹113 Cr |
| ₹32 Cr | -₹90,000 | ₹2 Cr | ₹3 Cr | ₹28 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹33 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹33 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹31 Cr | -₹116 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹16 Cr | ₹16 Cr |
| ₹661 Cr | ₹625 Cr | ₹591 Cr | ₹554 Cr | ₹523 Cr | ₹41 Cr | ₹30 Cr |
| ₹661 Cr | ₹625 Cr | ₹591 Cr | ₹554 Cr | ₹523 Cr | ₹41 Cr | ₹30 Cr |
| ₹680 Cr | ₹644 Cr | ₹610 Cr | ₹573 Cr | ₹542 Cr | ₹57 Cr | ₹46 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | -₹46,000 | ₹0 | ₹0 |
| ₹55 L | ₹2 Cr | ₹3 Cr | ₹40 L | ₹66 L | ₹1 Cr | ₹57 L |
| ₹17 Cr | ₹11 Cr | ₹2 Cr | ₹0 | ₹0 | ₹18 L | ₹20 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹90 L | -₹86 L |
| ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
| ₹22 Cr | ₹17 Cr | ₹8 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| — | — | — | — | — | — | — |
| ₹131 Cr | ₹79 Cr | ₹43 Cr | ₹28 Cr | ₹43 Cr | ₹28 Cr | ₹16 Cr |
| ₹142 Cr | ₹176 Cr | ₹113 Cr | ₹84 Cr | ₹58 Cr | ₹53 Cr | ₹47 Cr |
| ₹119 Cr | ₹108 Cr | ₹104 Cr | ₹104 Cr | ₹92 Cr | ₹17 Cr | ₹8 Cr |
| ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹87 L | ₹2 Cr | ₹29 L | ₹6 L |
| ₹395 Cr | ₹365 Cr | ₹262 Cr | ₹216 Cr | ₹194 Cr | ₹98 Cr | ₹72 Cr |
| ₹1097 Cr | ₹1026 Cr | ₹880 Cr | ₹793 Cr | ₹739 Cr | ₹157 Cr | ₹119 Cr |
| ₹65 Cr | ₹89 Cr | ₹92 Cr | ₹72 Cr | ₹61 Cr | ₹34 L | ₹25 L |
| ₹139 Cr | ₹123 Cr | ₹110 Cr | ₹105 Cr | ₹93 Cr | ₹19 Cr | ₹11 Cr |
| — | — | — | — | — | — | — |
| ₹275 Cr | ₹279 Cr | ₹274 Cr | ₹270 Cr | ₹267 Cr | ₹77 Cr | ₹56 Cr |
| ₹26 Cr | ₹29 Cr | ₹25 Cr | ₹25 Cr | ₹22 Cr | ₹39 Cr | ₹35 Cr |
| ₹249 Cr | ₹250 Cr | ₹249 Cr | ₹244 Cr | ₹245 Cr | ₹38 Cr | ₹21 Cr |
| ₹2 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹18,475 | ₹51 L |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹18,475 | ₹51 L |
| ₹63 Cr | ₹80 Cr | ₹53 Cr | ₹24 Cr | ₹22 Cr | ₹0 | ₹2 Cr |
| ₹319 Cr | ₹336 Cr | ₹309 Cr | ₹273 Cr | ₹272 Cr | ₹38 Cr | ₹23 Cr |
| — | — | — | — | — | — | — |
| ₹451 Cr | ₹338 Cr | ₹230 Cr | ₹208 Cr | ₹220 Cr | ₹77 Cr | ₹66 Cr |
| ₹85 Cr | ₹89 Cr | ₹94 Cr | ₹97 Cr | ₹86 Cr | ₹21 Cr | ₹12 Cr |
| ₹76 Cr | ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr |
| ₹1 Cr | ₹2 Cr | ₹46 L | ₹37 L | ₹39 L | ₹2 Cr | ₹46 L |
| ₹166 Cr | ₹172 Cr | ₹169 Cr | ₹176 Cr | ₹157 Cr | ₹17 Cr | ₹14 Cr |
| ₹779 Cr | ₹690 Cr | ₹572 Cr | ₹520 Cr | ₹468 Cr | ₹120 Cr | ₹96 Cr |
| ₹384 Cr | ₹325 Cr | ₹309 Cr | ₹303 Cr | ₹273 Cr | ₹22 Cr | ₹24 Cr |
| ₹1097 Cr | ₹1026 Cr | ₹880 Cr | ₹793 Cr | ₹739 Cr | ₹157 Cr | ₹119 Cr |
| ₹358 | ₹339 | ₹321 | ₹302 | ₹285 | ₹36 | ₹29 |
| ₹358 | ₹339 | ₹321 | ₹302 | ₹285 | ₹36 | ₹29 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|
| ₹46 Cr | ₹41 Cr | ₹42 Cr | ₹36 Cr | -₹63 Cr | ₹12 Cr | ₹0 |
| ₹11 Cr | ₹13 Cr | ₹10 Cr | ₹13 Cr | ₹102 Cr | ₹8 Cr | ₹0 |
| -₹69 Cr | -₹35 Cr | ₹23 Cr | -₹10 Cr | -₹19 Cr | -₹6 Cr | ₹0 |
| -₹12 Cr | ₹19 Cr | ₹75 Cr | ₹39 Cr | ₹20 Cr | ₹15 Cr | ₹0 |
| -₹13 Cr | ₹18 Cr | ₹75 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr | ₹0 |
| ₹3 Cr | -₹4 Cr | -₹27 Cr | -₹3 Cr | -₹20 Cr | -₹21 Cr | ₹0 |
| -₹4 Cr | -₹2 Cr | -₹8 Cr | -₹2 Cr | -₹22 Cr | ₹6 Cr | ₹0 |
| -₹13 Cr | ₹11 Cr | ₹39 Cr | ₹34 Cr | -₹25 Cr | -₹81 L | ₹0 |
| ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4 Cr | ₹29 Cr | ₹3 Cr | ₹0 |
| ₹76 Cr | ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4 Cr | ₹2 Cr | ₹0 |
Fundamental Ratios
Consolidated
Standalone

No results found
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 5 out of 9 oscillators
RSI
39.79Sell
STOCH %K
33.19Neutral
MACD Level(12,26)
-3.43Sell
Ultimate Oscillator
37.60Sell
Aroon Oscillator
-74.00Sell
BOP
0.25Buy
CCI
-43.01Neutral
Williams %R
-66.81Neutral
Momentum
-2.92Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
132.63Buy
SMA 9
131.73Buy
EMA 21
135.34Sell
SMA 21
134.47Sell
EMA 50
142.04Sell
SMA 50
143.55Sell
EMA 200
155.00Sell
SMA 200
154.26Sell
WMA 20
133.25Sell
Pivot
Pivot
Classic
Resistance 5
148.46
Resistance 4
144.50
Resistance 3
140.54
Resistance 2
136.58
Resistance 1
134.23
Pivot
132.62
Support 1
130.27
Support 2
128.66
Support 3
124.70
Support 4
120.74
Support 5
116.78
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
| 0.18% | 0.26% | 0.22% | 0.31% | 0.32% | 0.41% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.01% | 0.01% | 0.01% | 0.01% | 0.76% | 2.25% |
| 54.21% | 54.13% | 54.17% | 54.08% | 53.32% | 51.74% |
Bulk & block deals
Name
Aditya Birla Sun Life Mutual Fund
Bakulesh Trambaklal Shah
Bakulesh Shah Private Trust
Adroit Financial Services Pvt Ltd
Adroit Financial Services Pvt Ltd
Jainam Broking Limited
Jainam Broking Limited
Graviton Research Capital Llp
Graviton Research Capital Llp
Agri Tech India Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 19 Sep 2025 | Sell | 2.09 Cr | ₹165.08 | 1.27 L | Bulk | 0.667386 | NSE |
| 05 Mar 2025 | Purchase | 2.56 Cr | ₹152.50 | 1.68 L | Bulk | 0.884024 | BSE |
| 05 Mar 2025 | Sell | 2.56 Cr | ₹152.50 | 1.68 L | Bulk | 0.884024 | BSE |
| 04 Jul 2024 | Sell | 3.50 Cr | ₹262.20 | 1.33 L | Bulk | 0.701547 | NSE |
| 04 Jul 2024 | Purchase | 3.48 Cr | ₹261.12 | 1.33 L | Bulk | 0.701547 | NSE |
| 01 Jul 2024 | Purchase | 2.74 Cr | ₹245.86 | 1.11 L | Bulk | 0.586066 | NSE |
| 01 Jul 2024 | Sell | 16.76 L | ₹247.38 | 6.78 K | Bulk | 0.03565 | NSE |
| 01 Jul 2024 | Sell | 2.45 Cr | ₹236.15 | 1.04 L | Bulk | 0.546027 | NSE |
| 01 Jul 2024 | Purchase | 2.45 Cr | ₹236.35 | 1.04 L | Bulk | 0.546027 | NSE |
| 21 Feb 2024 | Sell | 10.94 Cr | ₹217 | 5.04 L | Block | 2.652073 | BSE |
Insider trading & SAST
Client name
Tapovan Paper And Board Mills Ltd & Others
Prabha Farms Private Limited
Paresh Farms Private Limited
Tapovan Paper And Board Mills Limited
Ferry Fax Farms Pvt. Ltd.
Aditya Birla Sun Life Mutual Fund
Emerald Seeds Private Limited
Agri - Tech (India) Ltd.
Agri-Tech (India) Ltd.
Ashu Farms Llp
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 Feb 2026 | Promoter | Acquisition | 0.4 | 45.6 | 0 | — | 75.64 K | 09 Jan 2026 | Sch.of Arrangement | 86,64,902 | SAST | 29(2) | — |
| 13 Jan 2026 | Promoter Group | Disposal | 0.39608 | 0 | 7.53 L | ₹10 | 75.27 K | 09 Jan 2026 | Scheme of Amalgamation/Merger/Demerger/Arrangement | 0 | Insider Trading | — | Equity Shares |
| 13 Jan 2026 | Promoter Group | Disposal | 0.001968 | 0 | 3.74 K | ₹10 | 374 | 09 Jan 2026 | Scheme of Amalgamation/Merger/Demerger/Arrangement | 0 | Insider Trading | — | Equity Shares |
| 13 Jan 2026 | Promoter Group | Acquisition | 0.398048 | 0.4 | 7.56 L | ₹10 | 75.64 K | 09 Jan 2026 | Scheme of Amalgamation/Merger/Demerger/Arrangement | 75,645 | Insider Trading | — | Equity Shares |
| 12 Jun 2025 | Promoter | Pledge | — | — | 0 | — | 2.25 L | 04 Jun 2025 | Release | 0 | SAST | Reg31 | — |
| 19 May 2025 | Other | Disposal | 2.08 | 3.2 | 0 | — | 3.95 L | 13 May 2025 | Market | 6,08,538 | SAST | 29(2) | — |
| 24 Dec 2024 | Promoter | Pledge | — | — | 0 | — | 6.90 L | - 30 Aug 2022 | Creation | 6,90,000 | SAST | Reg31 | — |
| 24 Dec 2024 | Promoter | Pledge | — | — | 0 | — | 6.30 L | - 01 Feb 2022 | Release | 0 | SAST | Reg31 | — |
| 24 Dec 2024 | Promoter | Pledge | — | — | 0 | — | 1 L | 30 Nov 2021 | Creation | 6,30,000 | SAST | Reg31 | — |
| 24 Dec 2024 | Promoter | Pledge | — | — | 0 | — | 6.50 L | 17 Jun 2021 | Release | 5,04,000 | SAST | Reg31 | — |
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Nath Bio-Genes is amongst the pioneering seed companies in India. The company has a strong Research & Development arm. It has research laboratories irrigated land testing facilities and farms all
Corporate Actions
Date
Type
Details
Company details
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Nath Bio-Genes (India) Share Price
132.67+0.01 (+0.60%)
-22.93% past 1 Year
News
Nath Bio-Genes: Q1 Sl Net Profit 38.20 Crores Rupees Vs 33.90 Crores (Yoy) || Q1 Revenue 280.00 Crores Rupees Vs 244.00 Crores (Yoy)
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes reports Profit after tax of 36.14 Crores, in the June 2025 quarter
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about updates
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about outcome of AGM
Equity
NATHBIOGEN
Nath Bio-Genes reports Profit after tax of 33.89 Crores, in the June 2024 quarter
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about loss of share certificate
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes - Quaterly Results
Equity
NATHBIOGEN
Nath Bio-Genes reports Profit after tax of 2.26 Crores, in the March 2024 quarter
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about compliances-certificate
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about EGM
Equity
NATHBIOGEN
Nath Bio-Genes (India) informs about disclosure
Equity
NATHBIOGEN
Nath Bio-Genes reports Profit after tax of 3.96 Crores, in the December 2023 quarter
Equity
NATHBIOGEN

